Recombinant Mouse TNFRSF10B (TRAIL R2)-Fc Chimera (carrier-free)

Pricing & Availability
Regulatory Status
Other Names
Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B), TNF-related apoptosis-inducing ligand receptor 2 (TRAIL R2), TRAIL receptor 2, Death receptor 5 (DR5), CD262, KILLER, TRICK2
Ave. Rating
Submit a Review
Product Citations
Mouse TNFRSF10B inhibits human TRAIL-mediated cytotoxicity on L929 cells
  • Mouse_TNFRSF10B_TRAIL-R2_RECOM_1_111417
    Mouse TNFRSF10B inhibits human TRAIL-mediated cytotoxicity on L929 cells
  • Mouse_TNFRSF10B_TRAIL-R2_RECOM_2_111417
    Mouse TNFRSF10B was aliquoted in PBS, pH 7.0 at 0.1 mg/ml and one aliquot was kept at 4°C (control), and another was freeze/thawed four times (4X freeze/thaws). After this procedure, the samples were tested for their ability to inhibit the cytotoxic effect induced by recombinant human TRAIL on mouse L929 cells.
Cat # Size Price Quantity Check Availability Save
768706 100 µg 287€
Check Availability

Need larger quantities of this item?
Request Bulk Quote

TNFRSF10B, also called TRAIL R2 and DR5, is a member of the TNF receptor superfamily. It contains a cysteine-rich extracellular domain, a transmembrane domain and an intracellular death domain, which mediates interactions between death receptor and death domain-containing adaptor proteins. When the trimeric ligand TRAIL (TNFSF10) is bound, homotrimer TNFRSF10B interacts with the adaptor protein Fas-associated death domain (FADD), in turn recruits caspase-8 and assembles a death-inducing signaling complex (DISC) that initiates apoptosis. There are decoy receptors, TRAIL R3 (DcR1), TRAIL R4 (DcR2), and OPG, which antagonize the apoptotic effect via competitive ligand binding. Several evidences indicated that TNFRSF10B play roles in tumorigenesis, immune response, and DNA damage response. Some studies have suggested that TNFRSF10B contributes more than TNFRSF10A (TRAIL R1) to TRAIL-induced apoptosis in cancer cells that express both receptors. In addition, agonistic monoclonal antibodies against TNFRSF10B, which can induce apoptosis in the absence of TRAIL, are used for cancer therapies. Loss of TNFRSF10B promotes lymphomagenesis and metastasis. Squamous cell carcinoma of the head and the neck may be caused by the mutation of TNFRSF10B. Recent study demonstrated that TNFRSF10B associates with CD40 and negatively regulates CD40L-induced NF-κB activation and proliferation in primary human B cells. The expression of TNFRSF10B is inducible and up-regulated by DNA damage in p53-dependent manner. The TNFRSF10B deficiency mice showed decreased survival after exposure to ionizing radiation. In human, there are three isoforms produced by alternative splicing. 

Product Details
Technical Data Sheet (pdf)

Product Details

Mouse TNFRSF10B, amino acid (Asn53-Ser177) (Accession: # BC065141), with a linker (GSSR) and a C-terminal human IgG (Pro100-Lys330), was expressed in 293E cells.
Molecular Mass
The 360 amino acid recombinant protein has a predicted molecular mass of approximately 40 kD. The DTT-reduced and non-reduced protein migrates at approximately 52 and 97 kD respectively by SDS-PAGE. The predicted N-terminal amino acid is Asn.
> 95%, as determined by Coomassie stained SDS-PAGE.
0.22 µm filtered protein solution is in 1x PBS.
Endotoxin Level
Less than 0.1 EU per µg cytokine as determined by the LAL method.
10 and 25 µg sizes are bottled at 200 µg/mL. 100µg and larger sizes are bottled at the concentration indicated on the vial.
Storage & Handling
Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles.
The ED50 is 3-12 ng/mL, as determined by inhibition of human TRAIL-mediated cytotoxicity (measured by Deep Blue Cell Viability™ Kit) on L929 cells in the presence of 12 ng/mL cross-linked human TRAIL and 1 µg/ml Actinomycin D.


Application Notes

BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are verified in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at

Antigen Details

Homodimer, disulfide bond-linked

Membrane; heart, lung, kidney, intestine, bladder, mammary gland, ovary, placenta.

TNFRSF10B play roles in tumorigenesis, immune response, and DNA damage response. TNFRSF10B induces apoptosis upon the binding of the ligand TNFSF10.
Biology Area
Apoptosis/Tumor Suppressors/Cell Death
Molecular Family
Cytokine/Chemokine Receptors, Soluble Receptors
Antigen References

1. Walczak H, et al. 1997. EMBO J. 16:5386.
2. Ashkenazi A. 2002. Nat. Rev. Cancer 2:420.
3. LeBlanc HN, et al. 2003. Cell Death Differ. 10:66.
4. Kelley RF, et al. 2005. J. Biol. Chem. 280:2205.
5. Johnstone RW, et al. 2008. Nat. Rev. Cancer. 8:782.
6. Wu GS, et al. 1997. Nat. Genet. 17:1413.
7. Wu GS, et al. 1999. Cancer Res. 59:2770-5.
8. Pai SI, et al. 1998. Cancer Res. 58:3513.
9. Finnberg N, et al. 2008. J. Clin. Invest. 118:111.
10. Grosse-Wilde A, et al. 2008. J. Clin. Invest. 118:100.
11. Finnberg N, et al. 2005. Mol. Cell. Biol. 25:2000.
12. Smulski CR, et al. 2017. Cell Death and Dis. 8:e2601.

Gene ID
21933 View all products for this Gene ID
View information about TNFRSF10B on

Related FAQs

Why choose BioLegend recombinant proteins?

     • Each lot of product is quality-tested for bioactivity as indicated on the data sheet.
     • Greater than 95% Purity or higher, tested on every lot of product.
     • 100% Satisfaction Guarantee for quality performance, stability, and consistency.
     • Ready-to-use liquid format saves time and reduces challenges associated with reconstitution.
     • Bulk and customization available. Contact us.
     • Learn more about our Recombinant Proteins.

How does the activity of your recombinant proteins compare to competitors?

We quality control each and every lot of recombinant protein. Not only do we check its bioactivity, but we also compare it against other commercially available recombinant proteins. We make sure each recombinant protein’s activity is at least as good as or better than the competition’s. In order to provide you with the best possible product, we ensure that our testing process is rigorous and thorough. If you’re curious and eager to make the switch to BioLegend recombinants, contact your sales representative today!

What is the specific activity or ED50 of my recombinant protein?

The specific activity range of the protein is indicated on the product datasheets. Because the exact activity values on a per unit basis can largely fluctuate depending on a number of factors, including the nature of the assay, cell density, age of cells/passage number, culture media used, and end user technique, the specific activity is best defined as a range and we guarantee the specific activity of all our lots will be within the range indicated on the datasheet. Please note this only applies to recombinants labeled for use in bioassays. ELISA standard recombinant proteins are not recommended for bioassay usage as they are not tested for these applications.

Have your recombinants been tested for stability?

Our testing shows that the recombinant proteins are able to withstand room temperature for a week without losing activity. In addition the recombinant proteins were also found to withstand four cycles of freeze and thaw without losing activity.

Does specific activity of a recombinant protein vary between lots?

Specific activity will vary for each lot and for the type of experiment that is done to validate it, but all passed lots will have activity within the established ED50 range for the product and we guarantee that our products will have lot-to-lot consistency. Please conduct an experiment-specific validation to find the optimal ED50 for your system.

How do you convert activity as an ED50 in ng/ml to a specific activity in Units/mg?
Use formula Specific activity (Units/mg) = 10e6/ ED50 (ng/mL)
Go To Top Version: 1    Revision Date: 11/15/2017

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.


*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.


BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587


Login / Register
Remember me
Forgot your password? Reset password?
Create an Account